WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Ownership - Who owns Alterity Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Alterity Therapeutics Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter Ashley MarksDirector2026-08-3147,620$0.50
$23.81kBuy

1 of 1

ATHE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHE insiders and whales buy or sell their stock.

ATHE Shareholders

What type of owners hold Alterity Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David Allen Stamler5.44%11,827,570$47.90MInsider
Lawrence Bernard Gozlan2.09%4,545,455$18.41MInsider
Peter Ashley Marks0.92%2,009,522$8.14MInsider
Niven Abby Sarah MacNish0.21%454,545$1.84MInsider
Twin Lakes Capital Management LLC0.00%139$562.95Institution
Morsta0.00%63$255.15Institution
Morgan Stanley0.00%63$255.15Institution
Greenleaf Trust0.00%62$251.10Institution
Greenl0.00%62$251.10Institution
Hb Wealth Management LLC0.00%58$234.90Institution

1 of 5

ATHE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHE0.00%8.66%Net BuyingNet Buying
TENX0.08%38.85%Net BuyingNet Buying
YARW0.05%99.95%Net SellingNet Selling
LONA0.06%99.94%Net Buying
CSBR0.00%100.00%Net Buying
View Top Biotech Stocks

Alterity Therapeutics Stock Ownership FAQ

Who owns Alterity Therapeutics?

Alterity Therapeutics (NASDAQ: ATHE) is owned by 0.00% institutional shareholders, 8.66% Alterity Therapeutics insiders, and 91.34% retail investors. David Allen Stamler is the largest individual Alterity Therapeutics shareholder, owning 11.83M shares representing 5.44% of the company. David Allen Stamler's Alterity Therapeutics shares are currently valued at $45.65M.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.